Coblyn JS - Search Results

1

Long-term prospective trial of low-dose methotrexate in rheumatoid arthritis.

Weinblatt ME, Trentham DE, Fraser PA, Holdsworth DE, Falchuk KR, Weissman BN, Coblyn JS. Weinblatt ME, et al. Among authors: coblyn js. Arthritis Rheum. 1988 Feb;31(2):167-75. doi: 10.1002/art.1780310203. Arthritis Rheum. 1988. PMID: 3279962 Clinical Trial.

2

Acute and chronic suppression of leukotriene B4 synthesis ex vivo in neutrophils from patients with rheumatoid arthritis beginning treatment with methotrexate.

Sperling RI, Benincaso AI, Anderson RJ, Coblyn JS, Austen KF, Weinblatt ME. Sperling RI, et al. Among authors: coblyn js. Arthritis Rheum. 1992 Apr;35(4):376-84. doi: 10.1002/art.1780350403. Arthritis Rheum. 1992. PMID: 1314609

3

Zileuton, a 5-lipoxygenase inhibitor in rheumatoid arthritis.

Weinblatt ME, Kremer JM, Coblyn JS, Helfgott S, Maier AL, Petrillo G, Henson B, Rubin P, Sperling R. Weinblatt ME, et al. Among authors: coblyn js. J Rheumatol. 1992 Oct;19(10):1537-41. J Rheumatol. 1992. PMID: 1334515 Clinical Trial.

4

Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis. 84-month update.

Weinblatt ME, Weissman BN, Holdsworth DE, Fraser PA, Maier AL, Falchuk KR, Coblyn JS. Weinblatt ME, et al. Among authors: coblyn js. Arthritis Rheum. 1992 Feb;35(2):129-37. doi: 10.1002/art.1780350202. Arthritis Rheum. 1992. PMID: 1734901 Clinical Trial.

5

The effects of cyclosporin A on eicosanoid excretion in patients with rheumatoid arthritis.

Weinblatt M, Helfgott S, Coblyn J, Spragg J, Uedelhoven WM, Tumeh S, Sperling R, Lorenz R, Maier A, Weber P. Weinblatt M, et al. Arthritis Rheum. 1991 Apr;34(4):481-5. doi: 10.1002/art.1780340413. Arthritis Rheum. 1991. PMID: 2012627

6

Inhibition of leukotriene B4 synthesis in neutrophils from patients with rheumatoid arthritis by a single oral dose of methotrexate.

Sperling RI, Coblyn JS, Larkin JK, Benincaso AI, Austen KF, Weinblatt ME. Sperling RI, et al. Among authors: coblyn js. Arthritis Rheum. 1990 Aug;33(8):1149-55. doi: 10.1002/art.1780330815. Arthritis Rheum. 1990. PMID: 2167685

7

The effect of cyclosporine on urinary kallikrein excretion in patients with rheumatoid arthritis.

Spragg J, Coblyn JS, Fraser PA, Austen KF, Weinblatt ME. Spragg J, et al. Among authors: coblyn js. Adv Exp Med Biol. 1989;247A:389-92. doi: 10.1007/978-1-4615-9543-4_59. Adv Exp Med Biol. 1989. PMID: 2603807

8

Rheumatoid aortitis: a rarely recognized but clinically significant entity.

Gravallese EM, Corson JM, Coblyn JS, Pinkus GS, Weinblatt ME. Gravallese EM, et al. Among authors: coblyn js. Medicine (Baltimore). 1989 Mar;68(2):95-106. Medicine (Baltimore). 1989. PMID: 2921941

9

Immunogenetic and racial determinants of gold toxicity in rheumatoid arthritis.

Fraser PA, Stern SH, Coblyn JS, Weinblatt ME, Holdsworth DE, Green P, Shriner S, Mindnich D, Larson M. Fraser PA, et al. Among authors: coblyn js. J Natl Med Assoc. 1988 Feb;80(2):162-5. J Natl Med Assoc. 1988. PMID: 2977188 Free PMC article.

10

Effect of cyclosporine on urinary kallikrein excretion in patients with rheumatoid arthritis.

Spragg J, Weinblatt ME, Coblyn J, Fraser P, Austen KF. Spragg J, et al. J Lab Clin Med. 1988 Sep;112(3):324-32. J Lab Clin Med. 1988. PMID: 3411194

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results